Aggarwal C, Maity AP, Bauml JM, Long Q, et al. A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer. Oncologist 2023 Apr 26:oyad106. doi: 10.1093.
PMID: 37186063